Definium Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -40,746 | -65,984 | -40,406 | -22,746 |
EBIT | -40,740 | -65,991 | ||
Net Income | -50,436 | -67,265 | -42,744 | -23,348 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -41,891 | -29,567 | -29,599 | -29,419 |
Cash | 257,837 | 19,959 | 33,392 | 82,854 |
Basic Shares | 89,327 | 85,885 | 85,347 | 87,091 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -527 | -3,162 | ||
EBITDA | -178,311 | -105,869 | -92,570 | -63,151 |
EBIT | -106,396 | -95,732 | -66,331 | |
Net Income | -183,793 | -108,679 | -95,732 | -56,796 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -131,560 | -79,129 | -64,365 | -50,139 |
Cash | 257,837 | 273,741 | 99,704 | 142,142 |
Basic Shares | 89,327 | 704,611 | 39,157 | 30,857 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.50 |
2025-09-30 | -$0.78 |
2025-06-30 | -$0.50 |
